Mark Richardson

Representation of SigmaRoc plc on its €1 billion acquisition of CRH's European lime business, as a reverse takeover

Representation of the Del Río family on the £1.3 billion business combination of Derco Group and Inchcape plc

Representation of Mutares on the €180m divestment of Special Melted Products, a UK based manufacturer of special steels and alloys, to Cogne Acciai Speciali

Representation of the shareholders of Tink AB, the Stockholm headquartered open banking platform, on its sale to Visa for €1.8 billion

Representation of French listed group SPIE on:

• its acquisition of Correll Electrical Engineering, a group specialising in electrical engineering and cabling; and
• the divestment of its UK business to Imtech

Representation of Neste, a Finnish group that is the leading producer of sustainable fuels and renewable feedstock solutions, on the divestment of its base oils business to Chevron

Representation of VALOREM, the French independent renewable energy developer and operator, on the divestment of the 165MW Kalistanneva wind farm in Finland to a consortium of HELEN Oy and the Bank of Åland Wind Power Fund"

Representation of European Bank for Reconstruction and Development (EBRD) as a founding investor on the creation of a US$750 million biopharmaceutical platform to broaden access to vital specialty generic drugs in Egypt, with the potential to expand into other countries in Africa.

Representation of MOL Hungarian Oil and Gas PLC on its US$1.57 billion deal with Chevron to acquire a 9.57 percent stake in the Azeri-Chirag-Gunashli (ACG) oil field in the Caspian Sea off Azerbaijan and an effective 8.90 percent interest in the Baku-Tbilisi-Ceyhan (BTC) pipeline running across Azerbaijan, Georgia and Türkiye to port facilities near Ceyhan, Türkiye.

Representation of Angelini, the Italian pharmaceutical and consumer healthcare group on its worldwide acquisition, outside North America, of the ThermaCare business from GlaxoSmithKline. The acquisition is a key transaction in relation to the creation of the GSK/Pfizer Consumer Healthcare Joint Venture.

Representation of an international mining company in relation to its acquisition of exploration assets in West Africa.

Representation of AFI Development Plc in connection with an offer by its majority shareholder, Flotonic Limited, to acquire all of the issued share capital of AFI not already held by Flotonic.

Representation of Grupo Mineros S.A. on their acquisition from Yamana Gold Inc. of 100 percent of the producing Gualcamayo gold mine in Argentina, and a portfolio of exploration assets in Chile.